AUTHORS
Suhana Basnyat, Amélie Collins, MD PhD2
AFFILIATIONS
1 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
2 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
ABSTRACT
Introduction: Maternal inflammation is a major driver of fetal and neonatal morbidity and mortality and is associated with fetal growth restriction, neurodevelopmental disorders, and metabolic diseases later in life. In adults, inflammatory stress induces emergency myelopoiesis (EM), a process in which hematopoietic stem and progenitor cells (HSPCs) expand and differentiate into myeloid cells to restore neutrophil pools. However, fetal hematopoietic stem cells (HSCs) fail to mount this regenerative process under inflammatory stress, which may contribute to impaired neonatal immune response. Our prior work demonstrated that in mice, systemic maternal inflammation restricts fetal myelopoiesis, resulting in neutropenia, and that absence of maternal IL-10 partially restores features of EM, including myeloid-biased HSC activation and progenitor expansion. These findings suggest that a maternal-derived signal regulates fetal hematopoietic adaptation.
Results: To identify metabolic pathways altered by maternal inflammation, we performed untargeted metabolomics and lipidomics on fetal livers from wild-type (WT) and IL-10-deficient (IL10-/-) dams exposed to lipopolysaccharide (LPS) or PBS. Mixed maternal-fetal dyads were generated by mating IL10-/- (KO) and IL10+/+(WT) females with males of the opposite genotype, ensuring that all fetuses were IL-10 heterozygous (IL10+/-). Mass spectrometry analysis identified broad remodeling of fetal liver metabolism, with amino acids representing the most prominently altered metabolite class. Among the altered metabolites, histidine was selectively depleted in fetal liver from LPS-exposed WT dams. Consistent with this finding, pathway and enrichment analyses also identified histidine metabolism as one of the significantly altered pathways, along with pathways involving histidine and histidine-derived intermediates, including beta-alanine metabolism. Other amino acids, including arginine, asparagine, and tyrosine, were depleted in fetuses from LPS-exposed WT dams and further enriched in fetuses from LPS-exposed KO dams. Acylcarnitine and fatty acid profiles also shifted in response to maternal inflammation, with both WT and KO LPS-exposed fetal livers showing increases in short-chain species such as AC(5:0) and FA(5:0). KEGG enrichment and pathway analyses further revealed that amino acid metabolism, acylcarnitine metabolism, and fatty acid oxidation are among the significantly altered pathways.
Based on the selective depletion of histidine and the alterations in histidine-associated metabolic pathways, we therefore focused on histidine as a candidate regulator of fetal myelopoiesis. Since histidine is an essential amino acid that cannot be synthesized de novo, we tested whether restoring histidine availability would rescue impaired fetal myelopoiesis induced by maternal inflammation. To assess this, WT dams were placed on a histidine-enriched diet at E12.5, followed by LPS challenge at E18.5. Histidine supplementation abrogated maternal inflammation-induced fetal HSPC depletion, preventing the loss of HSC and MPPs as observed in fetuses from LPS-exposed dams on a control diet. These data provide strong rationale for our hypothesis that histidine is required for fetal myelopoiesis.
Conclusion: Together, these findings demonstrate that maternal inflammation remodels metabolic pathways in the fetal liver and identify histidine depletion as a potential mechanism contributing to impaired fetal myelopoiesis in the presence of maternal inflammatory stress. Our findings suggest that histidine may function as a maternally derived metabolic signal regulating fetal hematopoietic adaptation. Importantly, restoration of histidine availability rescues fetal HSPC depletion induced by maternal inflammation. Ongoing studies are focused on defining how histidine and its downstream metabolites may regulate fetal hematopoietic function, specifically exploring a potential role for histidine in regulating protein translation required for fetal HSPC differentiation and function. Collectively, these results provide insight into how early-life exposures metabolically program fetal HSCs and shape postnatal immune function.
DISCLOSURES
Suhana Basnyat: No relevant conflicts of interest to declare.